Results 141 to 150 of about 507 (180)

Deficiency of multiple RNA silencing-associated genes may contribute to the increased susceptibility of Nicotiana benthamiana to viruses. [PDF]

Plant Cell Rep
Ludman M, Anita S, Fátyol K.
europepmc   +1 more source

Immunity gene silencing increases transient protein expression in Nicotiana benthamiana

Dodds IL, Watts EC, Schuster M, Buscaill P, Tumtas Y, Holton NJ, Song S, Stuttmann J, Joosten MHAJ, Bozkurt TO, van der Hoorn RAL.   +10 more
europepmc   +1 more source

Development of an African horse sickness VP6 DIVA diagnostic ELISA. [PDF]

Virol J
Tinarwo M, Dennis SJ, Hitzeroth II, Meyers AE, Rybicki EP, Mbewana S.   +5 more
europepmc   +1 more source

Development of a plant-based vaccine against brucellosis: stable expression of Brucella abortus OMP25 in transgenic tobacco. [PDF]

Transgenic Res
Qashqai M, Bertan E, Bertan E, Erisen S, Ozbek T, Vural-Korkut S.   +5 more
europepmc   +1 more source

Host cell protein impurities in therapeutic proteins: overview of advances in detection, nonconventional removal technologies and immunogenicity assessment. [PDF]

J Biol Eng
Alhuthali S, Pauzi SM, Kontoravdi C.
europepmc   +1 more source

Rhizobium rhizogenes A4-derived strains mediate hyper-efficient transient gene expression in Nicotiana benthamiana and other solanaceous plants. [PDF]

Plant Biotechnol J
Lopez-Agudelo JC, Goh FJ, Tchabashvili S, Huang YS, Huang CY, Lee KT, Wang YC, Wu Y, Chang HX, Kuo CH, Lai EM, Wu CH.   +11 more
europepmc   +1 more source

The landscape of antibody production systems: recombinant expression for research, diagnostics and therapy. [PDF]

Front Bioeng Biotechnol
Wenzel EV, Al-Halabi-Frenzel L, Demiral S, Frenzel A, Gnann DC, Keitel MC, Lehmler N, Mukherjee T, Rauls J, Schirrmann T, Stańczyk PG, Steinke S, Terbrack J, Westerhoff S, Dübel S, Schubert M, Hust M, Bertoglio F.   +17 more
europepmc   +1 more source

SBT5.2s are the major active extracellular subtilases processing IgG antibody 2F5 in the Nicotiana benthamiana apoplast

Beritza K, Buscaill P, Song S, Jutras PV, Huang J, Mach L, Dong S, van der Hoorn RAL.   +7 more
europepmc   +1 more source

Plant Molecular Pharming for the Treatment of Chronic and Infectious Diseases [PDF]

Annual Review of Plant Biology, 2014
Plant molecular pharming has emerged as a niche technology for the manufacture of pharmaceutical products indicated for chronic and infectious diseases, particularly for products that do not fit into the current industry-favored model of fermenter-based production campaigns.
Rainer Fischer, Julian K -C, Julian K-C   +2 more
exaly   +4 more sources

Protein modifications in the plant secretory pathway: current status and practical implications in molecular pharming [PDF]

Vaccine, 2005
Plants have become, over the last ten years, a suitable alternative to microbial and animal cell factories for the production of clinically-useful, therapeutic proteins. Besides the well known advantage of low-cost and large-scale production of safe and biologically active mammalian proteins, plants also are able to perform most post-translational ...
Dominique Michaud
exaly   +5 more sources